Turk J Ophthalmol 2018 / 3
TR
/
EN
Home Page
About Us
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Archive
Author Index
Turkish Ophthalmological Association Web Page
Archive
Author Index
Turkish Ophthalmological Association Web Page
TR
/
EN
E-ISSN:2147-2661
EN E-ISSN:2149-8709
Toggle navigation
TR
/
EN
Home Page
About Us
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Original Article
Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
Işıl Sayman Muslubaş
Mümin Hocaoğlu
Serra Arf
Hakan Özdemir
Murat Karaçorlu
Turk J Ophthalmol 2016; 46: 16-20
DOI: 10.4274/tjo.19981
PMID:27800252
Full
Text
Read
PDF
The Effect of Intravitreal Bevacizumab on Apoptosis of Rat Retina Cells
Özcan Kayıkçıoğlu
Seda Vatansever
İsmet Topçu
Işıl Aydemir
Tuğçe Bilecenoğlu
Fatih Kahvecioğlu
Sinan Emre
Turk J Ophthalmol 2013; 43: 39-44
DOI: 10.4274/tjo.43.07279
Full
Text
Read
PDF
Comparison between efficacy of intravitreal triamcinolone acetonide and bevacizumab on visual acuity in retinal branch vein occlusion
Mustafa Alpaslan Anayol
Yasin Toklu
Sabri Raza
Ayşe Gül Koçak Altıntaş
Şaban Şimşek
Turk J Ophthalmol 2009; 39: 115-120
Full
Text
Read
PDF
Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion
Banu Aytuğ
Ateş Yanyalı
Ahmet Fazıl Nohutçu
Turk J Ophthalmol 2009; 39: 121-128
Full
Text
Read
PDF
Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia
Ökkeş Baz
İhsan Yılmaz
Cengiz Alagöz
Ali Demircan
İrfan Perente
Abdullah Özkaya
Muhittin Taşkapılı
Turk J Ophthalmol 2017; 47: 144-148
DOI: 10.4274/tjo.04874
PMID:28630789
Full
Text
Read
PDF
Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: Early Results
Ceylan Uslu
Gökhan İbrahim Gülkılık
Ersin Oba
Banu Arslan
Turk J Ophthalmol 2010; 40: 145-150
DOI: 10.4274/tod.40.145
Full
Text
Read
PDF
The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
Cengiz Alagöz
Yusuf Yıldırım
Murat Kocamaz
Ökkeş Baz
Uğur Çiçek
Burcu Çelik
Halil İbrahim Demirkale
Ahmet Taylan Yazıcı
Muhittin Taşkapılı
Turk J Ophthalmol 2016; 46: 221-225
DOI: 10.4274/tjo.82542
PMID:28058164
Full
Text
Read
PDF
Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
Tuğba Aydoğan
Gürkan Erdoğan
Cihan Ünlü
Ahmet Ergin
Turk J Ophthalmol 2016; 46: 270-273
DOI: 10.4274/tjo.23921
PMID:28050323
Full
Text
Read
PDF
The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
Şehnaz Özçalışkan
Pelin Yılmazbaş
Faruk Öztürk
Özlem Beyazyıldız
Turk J Ophthalmol 2014; 44: 361-364
DOI: 10.4274/tjo.26122
Full
Text
Read
PDF
Letter to Editor
Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
Beuy Joob
Viroj Wiwanitkit
Turk J Ophthalmol 2017; 47: 123-124
DOI: 10.4274/tjo.91328
PMID:28405490
Full
Text
Read
PDF
Case Report
Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis
Sirel Gür Güngör
İmren Akkoyun
Evin Singar
Gürsel Yılmaz
Turk J Ophthalmol 2014; 44: 237-239
DOI: 10.4274/tjo.29494
Full
Text
Read
PDF
Original Article
Comparison of Corneal Endothelial Changes After a Single-Dose Injection of Bevacizumab or Ranibizumab
Fatih Horozoğlu
Tansu Gönen
Mustafa Yaşar
Özkan Sever
Kadircan Keşkinbora
Turk J Ophthalmol 2013; 43: 391-394
DOI: 10.4274/tjo.82621
Full
Text
Read
PDF
Advanced Search
About Journal
Article Tools
Ahead of Print
Submit Online Article
Review an Article
Forms
Permission Form
Copyright Transfer Form
Society
TODNet News
TODNet Dictionary
Bookcase
Useful Links
ICMJE Recommendations
EndNote
Crossref
Subscribe
×
×
Subscribe
Full Name
E-mail